4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-022749
CHIEF FINANCIAL OFFICER sold 54,491 shares at $2.85 ($155,299)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran CHIEF FINANCIAL OFFICER | 2025-08-21 | Sale | −54,491 | $2.85 | $155,299 | 1,187,603 | D |
| Open-market sales · 54,491 sh · avg $2.85 · $155,299 | |||||||
Loading xslF345X05/form4-08222025_040804.xml…